Literature DB >> 32324658

Augmented intelligence in pediatric anesthesia and pediatric critical care.

Matthias Görges1,2, J Mark Ansermino1,2.   

Abstract

PURPOSE OF REVIEW: Acute care technologies, including novel monitoring devices, big data, increased computing capabilities, machine-learning algorithms and automation, are converging. This enables the application of augmented intelligence for improved outcome predictions, clinical decision-making, and offers unprecedented opportunities to improve patient outcomes, reduce costs, and improve clinician workflow. This article briefly explores recent work in the areas of automation, artificial intelligence and outcome prediction models in pediatric anesthesia and pediatric critical care. RECENT
FINDINGS: Recent years have yielded little published research into pediatric physiological closed loop control (a type of automation) beyond studies focused on glycemic control for type 1 diabetes. However, there has been a greater range of research in augmented decision-making, leveraging artificial intelligence and machine-learning techniques, in particular, for pediatric ICU outcome prediction.
SUMMARY: Most studies focusing on artificial intelligence demonstrate good performance on prediction or classification, whether they use traditional statistical tools or novel machine-learning approaches. Yet the challenges of implementation, user acceptance, ethics and regulation cannot be underestimated. Areas in which there is easy access to routinely labeled data and robust outcomes, such as those collected through national networks and quality improvement programs, are likely to be at the forefront of the adoption of these advances.

Entities:  

Mesh:

Year:  2020        PMID: 32324658     DOI: 10.1097/ACO.0000000000000845

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  1 in total

1.  A pharmacometrician's role in enhancing medication use in pregnancy and lactation.

Authors:  Sara K Quinney; Peter L Bonate
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-08       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.